SCHEMBL17201431

SCHEMBL17201431

Clc1cccc(Cl)c1COc1ccc(-c2ccon2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP19A1 P11511 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.53
RAB9A P51151 3/20 0.51
KDM4E B2RXH2 1/20 0.51
KMT2A Q03164 3/20 0.44
NPC1 O15118 1/20 0.41
MEN1 O00255 2/20 0.40
MAPT P10636 3/20 0.40
NR1H4 Q96RI1 9/20 0.40
FABP1 P07148 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201423 0.91 SMN1; SMN2 (0.64) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201437 0.84 CYP1A2 (0.54) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201427 0.80 DHFR (0.56) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774756 0.78 CYP1A2 (0.56) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL27331802 0.77 SMN1; SMN2 (0.53) SMN1; SMN2RAB9AKDM4EKMT2AMEN1
SCHEMBL15774381 0.77 CYP1A2 (0.51) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL17201422 0.75 CYP1A2 (0.49) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL27331707 0.75 NOTUM (0.58) SMN1; SMN2RAB9AKMT2ANPC1MEN1
SCHEMBL27331814 0.75 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AKDM4EKMT2AMAPT
SCHEMBL17201432 0.74 CYP1A2 (0.58) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296711-B2 Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1) HOFFMAN-LA ROCHE INC. (US) 2016-03-29 US disclosed
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) HOFFMANN-LA ROCHE INC. 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) SCD, SCD5, CPT1A CYP1A2 368/4885CYP2D6 747/4885CYP19A1 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.